
About Mbd Pharma
Mbd Pharma is a Healthcare company based in Noida (India). Distributes and manufactures pharmaceutical bulk drugs, excipients, and finished formulations. It operates on a B2B model. Its Indian entity Mbd Pharma Private Limited reported revenue of βΉ64.5 Lakh. Its focus areas include Pharmaceuticals, Drug Manufacturing and Bulk Drugs and Formulations. Similar companies include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed similar companies have raised funding.
Company details
Mbd Pharma distributes and manufactures pharmaceutical bulk drugs, excipients, and finished formulations, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs and formulations. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
- Headquarters Noida, India
- SectorsHealthcare
- Website mbdpharma.com
- Legal Name Mbd Pharma Private Limited
- Date of Incorporation 03 May, 2013
- Jurisdiction Sahibabad, Uttar Pradesh, India
- Annual Revenue₹64.5 Lakh
FY 2022 · -17% YoY
- Net Loss-₹5.6 Lakh
FY 2022 · -9% margin
- EBITDA-₹2.5 Lakh
FY 2022 · -4% margin
Associated legal entities of Mbd Pharma
Mbd Pharma operates through Mbd Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2022) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Mbd Pharma Private Limited CIN U24233UP2013PTC056729 | Active | 03 May 2013 | Sahibabad, Uttar Pradesh | ₹0.6 Cr | 2 | View details |
Board of directors of Mbd Pharma Private Limited (Mbd Pharma)
Mbd Pharma Private Limited is the primary company behind Mbd Pharma. The board of Mbd Pharma Private Limited currently have 2 directors; the longest-serving is Harsh Vardhan Sharma, appointed in 2020. 7 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Harsh Vardhan Sharma DIN 03524505 | Director | 05 Oct 2020 | 6 yrs 1 mo | Mbd Pharma Private Limited |
| Anil Kumar Goswami DIN 02604065 | Director | 21 Jul 2021 | 5 yrs 4 mo | Mbd Pharma Private Limited |
Financials of Mbd Pharma
Figures of Mbd Pharma Private Limited, the primary company behind Mbd Pharma, for FY 2022. Revenue was ₹64.5 Lakh (-17% year on year). Net loss was -₹5.6 Lakh (-9% margin). EBITDA was -₹2.5 Lakh (-4% margin). Revenue has grown at a compounded annual rate of +210% over three years and +186% over five years.
- ₹64.5 LakhRevenue · FY 2022 · -17% YoY
- -₹5.6 LakhNet loss · -9% margin
- -₹2.5 LakhEBITDA · -4% margin
- ₹1 LakhPaid-up capital
- +210%Revenue CAGR, 3 years
- +186%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Mbd Pharma Private Limited are on its company page.
Detailed financial statements for Mbd Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Similar companies to Mbd Pharma
Mbd Pharma has 3 listed similar companies in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| lauruslabs.com | 2005 | Hyderabad, India | $229.73M | 6,035 | Pharmaceutical and biotechnology company | |
| symbiotec.in | 2002 | Indore, India | $61.01M | 1,822 | Non-sterile steroid hormone-based APIs and intermediates are manufactured. | |
| sequent.in | 2002 | Bengaluru, India | APIs are developed and manufactured for therapeutic areas. |
Detailed similar companies of Mbd Pharma
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Mbd Pharma
Mbd Pharma is headquartered in Noida, India. It is registered at Noida, Uttar Pradesh, India.
The primary company behind Mbd Pharma, Mbd Pharma Private Limited, reported revenue of βΉ64.5 Lakh for FY 2022, down 17% year on year.
Mbd Pharma distributes and manufactures pharmaceutical bulk drugs, excipients, and finished formulations, focusing on providing healthcare solutions, producing pharmaceutical products, drug manufacturing, and bulk drugs and formulations. It serves clients with dedicated solutions, emphasizing quality, innovation, and sustainable growth in its core markets.
Mbd Pharma's top competitors include Laurus Labs, Symbiotec and SeQuent.
Mbd Pharma operates through Mbd Pharma Private Limited.
The legal entities of Mbd Pharma currently have 2 directors, including Anil Kumar Goswami, Harsh Vardhan Sharma.